000			03899nam a22003017a 4500
001			20241101105632.0
003			OCoLC
005			20241101110315.0
008			241101b |||||||| |||| 00| 0 eng d
020			_a 978-3-030-76262-9
020			_a978-3-030-76263-6 (eBook)
022			_a 2523-8027
022			_a 2523-8035 (electronic)
040			_cddc
041			_aEnglish
100			_qMuthupandian Saravanan
222			_aacid activity Advanced apoptosis applications biocompatibility biological Biomaterials brain breast cancer cancer cells Cancer Nanotheranostics cancer theranostics cancer therapy carbon nanotubes carriers cell lines cellular chemical Chemistry chemotherapeutic chemotherapy Chen chitosan clinical trials conjugated contrast agents Controlled Release cytotoxicity delivery systems dendrimer detection diagnosis disease DNA doxorubicin drug delivery drug release effects efficacy efficient encapsulated enhanced evaluation FDA Fig fluorescence formulation functional gene gold nanoparticles graphene H https://doi https://www imaging International Journal iron oxide ligands lipid liposomes Liu magnetic Materials medicine membrane method micelles microswimmers molecular molecules MRI MTT assay multifunctional nanobiomaterials nanocarriers nanoformulations nanomaterials Nanomedicine nanoparticles nanoplatforms Nanoscale nanostructures Nanotechnology nanotheranostic agent Nanotoxicology near-infrared NIR nm NPs oxide nanoparticles paclitaxel particle patients PDT peptide photodynamic therapy photothermal therapy PLGA polymer polymeric potential protein PTT receptor Research safety silver nanoparticles Spherical studies surface synthesis targeting techniques theranostic therapeutic tion tissues toxicity treatment tumor uptake vitro vivo Wang Zhang.
245			_aCancer Nanotheranostics.
260			_aDepartment of Pharmacology Saveetha Dental College Saveetha Institute of Medical and Technical Sciences (SIMATS) Chennai, India | _b Springer Nature Switzerland AG | _c2021
300			_a379 Pages
300			_aIncludes References
490			_a Nanotechnology in the Life Sciences _vVolume 2
520			_aCancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.
600			_xCancer, Medical / General, Medical / Oncology / General, Nanobiotechnology, Nanomedicine, Science / Biotechnology, Technology & Engineering / Materials Science / General, Biotechnology, Cancer -- Research, Cancer -- Treatment -- Technological innovations -- Diagnosis, Electronic books, Materials science, Nanostructured materials.
700			_q Hamed Barabadi
856			_u https://doi.org/10.1007/978-3-030-76263-6
942			_2ddc _cEB _n0
999			_c29522 _d29522